相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Yoon Kong Loke et al.
BRITISH MEDICAL JOURNAL (2011)
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Emily Herrett et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population
Debra A. Wertz et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Rapid Identification of Myocardial Infarction Risk Associated With Diabetes Medications Using Electronic Medical Records
John S. Brownstein et al.
DIABETES CARE (2010)
Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone
David J. Graham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD)
Dori Bilik et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
The Thiazolidinediones Rosiglitazone and Pioglitazone and the Risk of Coronary Heart Disease: A Retrospective Cohort Study Using a US Health Insurance Database
Najat Ziyadeh et al.
CLINICAL THERAPEUTICS (2009)
Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients
Alain Vanasse et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Thiazolidinediones and Cardiovascular Events in Patients with Type 2 Diabetes Mellitus A Retrospective Cohort Study of over 473 000 Patients Using the National Health Insurance Database in Taiwan
Fei-Yuan Hsiao et al.
DRUG SAFETY (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
Colin R. Dormuth et al.
PLOS ONE (2009)
Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications
Karen M. Stockl et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis
Zeina A. Habib et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Association Between Extent of Thiazolidinedione Exposure and Risk of Acute Myocardial Infarction
David D. Dore et al.
PHARMACOTHERAPY (2009)
A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example
Tjeerd-Pieter van Staa et al.
PLOS MEDICINE (2009)
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
Ioanna Tzoulaki et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
David N. Juurlink et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy
Wolfgang C. Winkelmayer et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007
Alexander M. Walker et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
An assessment of the effect of thiazolidinedione exposure on the risk of myocardial infarction in type 2 diabetic patients
Carol E. Koro et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Association between serious ischemic cardiac outcomes and medications used to treat diabetes
David J. Margolis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes
Lorraine L. Lipscombe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial infarction in type 2 diabetest
Charles M. Gerrits et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Rodrigo M. Lago et al.
LANCET (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Coronary heart disease outcomes in patients receiving antidiabetic agents
Andrew T. McAfee et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy
Catherine B. Johannes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database
Frank de Vries et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Pioglitazone initiation and subsequent hospitalization for congestive heart failure
AJ Karter et al.
DIABETIC MEDICINE (2005)
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure - An observational study
FA Masoudi et al.
CIRCULATION (2005)
Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: A retrospective data analysis
R Rajagopalan et al.
CLINICAL THERAPEUTICS (2004)
分享论文
